PubMed

Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study.

PMID: 33055121 · 2020-10-14

J, a, m, e, s, , A, n, d, r, e, w, , S, m, i, t, h, ;, , R, o, x, a, n, n, a, , E, , A, b, h, a, r, i, ;, , Z, a, i, n, , H, u, s, s, a, i, n, ;, , C, a, r, l, , H, e, n, e, g, h, a, n, ;, , G, a, r, y, , S, , C, o, l, l, i, n, s, ;, , A, n, d, r, e, w, , J, , C, a, r, r

ЖурналBMJ open

Год2020-10-14

PMID33055121

Аннотация

To determine the extent and disclosure of financial ties to industry and use of scientific evidence in comments on a US Food and Drug Administration (FDA) regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD). Cross-sectional study. We searched all publicly available comments on the FDA 'Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Devi

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.